Benjamin Deitert
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.
Journal: International journal of cancer
Published: February 18, 2026
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 12, 2025
Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma.
Journal: Cancers
Published: May 19, 2025
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?
Journal: Frontiers in immunology
Published: February 13, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
Journal: EMBO molecular medicine
Published: September 12, 2023
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2023
Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors.
Journal: Cancer metastasis reviews
Published: September 02, 2022
Current and Future Clinical Applications of ctDNA in Immuno-Oncology.
Journal: Cancer research
Published: May 28, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026